SuperPath approach is a recommendable option in frail patients with femoral neck fractures: a case-control study.


Journal

Archives of orthopaedic and trauma surgery
ISSN: 1434-3916
Titre abrégé: Arch Orthop Trauma Surg
Pays: Germany
ID NLM: 9011043

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 22 06 2021
accepted: 31 08 2021
pubmed: 6 9 2021
medline: 4 10 2022
entrez: 5 9 2021
Statut: ppublish

Résumé

The treatment of intracapsular femoral neck fractures (FNFs) in the elderly is usually based on hip replacement, both total hip arthroplasty (THA) and hemiarthroplasty (HA). Recently, several tissue-sparing approaches for hip arthroplasty had been described with promising results in terms of hospitalization length, blood loss and dislocation rate. The aim of the present study was to compare the blood loss and the transfusion rate in a cohort of patients with FNF treated using an HA through both the SuperPath (SP) and the traditional posterolateral (PL) approaches. We retrospectively collected data from patients affected by FNFs between January 2018 and February 2020. All patients with intracapsular FNF treated with a single HA implant (Profemur L, MicroPort Orthopedics Inc., USA) via PL or SP approaches were included. Exclusion criteria were pathological fractures, polytrauma and preoperatively transfused patients. Thirty-five patients were included and analysed in the present study. 17 patients were classified in the SP group, and 18 in the PL one. The rate of antithrombotic therapy was higher in the SP group compared with the PL group [10 (58, 82%) vs 4 (22, 2%)]. While the two groups did not differ in terms of preoperative haemoglobin (Hb), 48 h postoperative Hb and Hb reduction, a significative difference was observed in terms of blood transfusion rate (1 SP vs 9 PL, p = 0.0072). The SuperPath approach in patients with FNF under antithrombotic therapy assures lower transfusion rate, potentially reducing complication rates and improving patients' outcomes.

Identifiants

pubmed: 34482424
doi: 10.1007/s00402-021-04153-y
pii: 10.1007/s00402-021-04153-y
pmc: PMC9522763
doi:

Substances chimiques

Fibrinolytic Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3265-3270

Informations de copyright

© 2021. The Author(s).

Références

Injury. 2021 Aug;52(8):2407-2414
pubmed: 33810845
Bone Joint J. 2018 Jul;100-B(7):853-861
pubmed: 29954218
Orthop Traumatol Surg Res. 2019 Feb;105(1S):S95-S101
pubmed: 30449680
Curr Opin Anaesthesiol. 2008 Oct;21(5):664-8
pubmed: 18784496
Minerva Anestesiol. 2006 May;72(5):283-98
pubmed: 16675937
J Bone Jt Infect. 2019 Apr 20;4(2):99-105
pubmed: 31192107
Injury. 2019 Dec;50(12):2282-2286
pubmed: 31610945
Mo Med. 2018 Nov-Dec;115(6):537-541
pubmed: 30643349
J Bone Joint Surg Am. 2008 Sep;90(9):1884-90
pubmed: 18762648
J Arthroplasty. 2019 Aug;34(8):1837-1843.e2
pubmed: 31060915
J Arthroplasty. 2020 Jun;35(6S):S262-S267
pubmed: 32222266
J Orthop Traumatol. 2017 Nov;18(Suppl 1):3-36
pubmed: 29058226
Transfusion. 1991 May;31(4):318-23
pubmed: 2020994
Osteoporos Int. 2019 Mar;30(3):583-591
pubmed: 30498889
Eur J Orthop Surg Traumatol. 2019 Jan;29(1):103-110
pubmed: 29860674
Hip Int. 2021 Mar;31(2):272-279
pubmed: 31912747
Med Sci Monit. 2020 Jan 21;26:e919993
pubmed: 31961830
J Orthop Surg Res. 2019 Jul 4;14(1):203
pubmed: 31272470
Med Sci Monit. 2020 Feb 19;26:e920255
pubmed: 32074099
J Orthop Surg Res. 2016 Oct 12;11(1):113
pubmed: 27733183
BMC Anesthesiol. 2018 Sep 5;18(1):121
pubmed: 30185155
Hip Int. 2018 Nov;28(2_suppl):84-88
pubmed: 30755118
J Clin Oncol. 2000 Jul;18(14):2755-61
pubmed: 10894876
Transfusion. 2012 Sep;52(9):1983-8
pubmed: 22313531
Clin Orthop Relat Res. 2014 Sep;472(9):2779-89
pubmed: 24771260
Osteoporos Int. 2011 May;22(5):1277-88
pubmed: 21461721
J Clin Oncol. 1998 Jul;16(7):2364-70
pubmed: 9667252
J Arthroplasty. 2017 Jan;32(1):150-154
pubmed: 27480829
JBJS Essent Surg Tech. 2019 May 08;9(2):e17
pubmed: 31579535
Injury. 2019 Aug;50(8):1452-1459
pubmed: 31208778
Orthop Surg. 2020 Feb;12(1):74-85
pubmed: 31885193
J Clin Med. 2020 Oct 03;9(10):
pubmed: 33023020

Auteurs

Antonio Benedetto Cecere (AB)

Department of Medical and Surgical Specialties and Dentistry, University of Campania "Luigi Vanvitelli", Via L. De Crecchio 4, 80138, Naples, Italy.

Annalisa De Cicco (A)

Department of Medical and Surgical Specialties and Dentistry, University of Campania "Luigi Vanvitelli", Via L. De Crecchio 4, 80138, Naples, Italy.

Gaetano Bruno (G)

Unit of Orthopaedics and Traumatology, AORN Sant'Anna E San Sebastiano, Caserta, Italy.

Giuseppe Toro (G)

Department of Medical and Surgical Specialties and Dentistry, University of Campania "Luigi Vanvitelli", Via L. De Crecchio 4, 80138, Naples, Italy. giusep.toro@gmail.com.

Giacomo Errico (G)

Unit of Orthopaedics and Traumatology, AORN Sant'Anna E San Sebastiano, Caserta, Italy.

Adriano Braile (A)

Department of Medical and Surgical Specialties and Dentistry, University of Campania "Luigi Vanvitelli", Via L. De Crecchio 4, 80138, Naples, Italy.

Alfredo Schiavone Panni (A)

Department of Medical and Surgical Specialties and Dentistry, University of Campania "Luigi Vanvitelli", Via L. De Crecchio 4, 80138, Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH